GLRA1 Protein

📖 Wiki Page

protein1548 wordssynced 2026-04-02

GLRA1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GLRA1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Glycine Receptor Alpha-1</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GLRA1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P23415</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~53 kDa (glycosylated)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Cys-loop ligand-gated ion channel</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Postsynaptic membrane, neuronal soma and dendrites</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>Spinal cord, brainstem, [hippocampus](/brain-regions/hippocampus), cerebellum, cerebral [cortex](/brain-regions/cortex)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>450 amino acids</td>
</tr>
<tr>
<td class="label">PDB Structure</td>
<td>5CMH, 5CKB, 6LUX</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">GLRB</td>
<td>Subunit assembly</td>
</tr>
<tr>
<td class="label">Gephyrin</td>
<td>Postsynaptic scaffold</td>
</tr>
<tr>
<td class="label">Collybistin</td>
<td>Membrane-associated guanylate kinase</td>
</tr>
<tr>
<td class="label">Radixin</td>
<td>Cytoskeletal protein</td>
</tr>
<tr>
<td class="label">PSD-95 family</td>

...

GLRA1 Protein

Introduction

GLRA1 Protein (Glycine Receptor Alpha-1) is a critical ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system. This protein is encoded by the GLRA1 gene and is essential for motor control, sensory processing, and respiratory regulation. Mutations in GLRA1 cause hyperekplexia (startle disease), a neurological disorder characterized by exaggerated startle responses and neonatal apnea. In the context of neurodegeneration, glycine receptor dysfunction may contribute to excitatory-inhibitory imbalance in motor neuron diseases and age-related neurological conditions. [@neurodegenerative]

Overview

GLRA1 is a member of the Cys-loop receptor family, which includes GABA_A, nicotinic [acetylcholine](/entities/acetylcholine), and 5-HT3 receptors. These receptors are pentameric ligand-gated ion channels that mediate rapid synaptic inhibition. The glycine receptor alpha-1 subunit (GLRA1) combines with beta subunits (GLRB) to form functional receptors in the spinal cord, brainstem, and select brain regions. [@alzheimers]

The receptor plays a fundamental role in motor control by inhibiting motor [neurons](/entities/neurons) and interneurons in the spinal cord. It is particularly important for the modulation of stretch reflexes, motor coordination, and the timing of muscle activation. Additionally, glycine receptors in the brainstem are essential for respiratory control, with mutations leading to life-threatening apnea in newborns. [@nih]

Protein Information

Structure

Protein Domains

The GLRA1 protein contains several distinct structural domains:

N-terminal Extracellular Domain (ECD): The first ~220 amino acids form the ligand-binding domain that contains the characteristic Cys-loop motif (a 13-amino acid disulfide-bridged loop). This domain contains the glycine binding site at the interface between adjacent subunits.

Transmembrane Domain (TMD): Four alpha-helical transmembrane segments (M1-M4) that form the ion channel pore. The M2 helix line the channel pore and determine ion selectivity (Cl⁻ conductance).

Intracellular Loop: The loop between M3 and M4 domains is intracellular and contains sites for phosphorylation and protein interactions.

C-terminal Domain: Involved in receptor clustering and synaptic localization via interaction with gephyrin.

Glycine Binding Site

The glycine binding site is located at the interface between two adjacent subunits in the ECD. Key binding site residues include:

Phenylalanine 159 and Proline 160 (loop B)
Asparagine 200 and Threonine 204 (loop C)
The binding site requires both alpha subunits to be present for high-affinity glycine binding

Post-translational Modifications

GLRA1 undergoes several modifications:

N-linked glycosylation at multiple asparagine residues
Palmitoylation at cysteine residues in the TMD
Phosphorylation at serine and threonine residues (affects receptor desensitization)

Molecular Function

Ion Channel Physiology

GLRA1 forms a pentameric chloride channel with the following properties:

Ion Selectivity: Highly selective for chloride (Cl⁻) over other anions
Conductance: Single channel conductance of ~40-90 pS depending on subunit composition
Activation: Rapid activation (τ ~5-10 ms) upon glycine binding
Desensitization: Biphasic desensitization (fast τ ~50 ms, slow τ ~500 ms)
Deactivation: Rapid deactivation upon glycine unbinding

Signaling Pathways

Inhibitory Transmission: Glycine binding opens the channel, allowing Cl⁻ influx, which hyperpolarizes the neuron and reduces excitability.

Gephyrin Clustering: GLRA1 interacts with gephyrin to form postsynaptic scaffold structures that anchor receptors at inhibitory synapses.

Phosphorylation Regulation: PKC and PKA phosphorylation modulate receptor activity and trafficking.

Allosteric Modulation: Agents like strychnine (antagonist), ivermectin (positive modulator), and ethanol can modulate receptor function.

Protein Interactions

Expression Pattern

Regional Distribution

GLRA1 is predominantly expressed in:

Spinal Cord: Highest density in laminae I-II (substantia gelatinosa), motor horns
Brainstem: Nucleus tractus solitarius, vestibular nuclei, cochlear nuclei
Hippocampus: CA1-CA3 pyramidal cells, interneurons
Cerebellum: Granule cells, Purkinje cell layer
Cerebral Cortex: Layer 1 interneurons, some pyramidal neurons

Cellular Localization

Postsynaptic Density: Concentrated at inhibitory synapses on neuronal soma and proximal dendrites
Extrasynaptic: Present at lower density outside synaptic junctions
Presynaptic: Some evidence for presynaptic glycine receptors modulating neurotransmitter release

Development

GLRA1 expression undergoes developmental regulation:

Embryonic expression in spinal cord precedes functional synapse formation
Postnatal maturation includes changes in subunit composition
Adult receptors have distinct pharmacological properties from embryonic forms

Role in Neurodegeneration

While GLRA1 is not directly implicated in primary neurodegenerative diseases, it plays important roles in motor neuron circuits that degenerate in conditions like ALS:

Amyotrophic Lateral Sclerosis (ALS)

Excitotoxicity: Dysregulation of inhibitory glycine signaling may contribute to excitotoxicity in motor neurons
Respiratory Failure: Brainstem glycine receptors are critical for respiratory control; their dysfunction may contribute to respiratory failure in ALS
Motor Circuit Dysfunction: Loss of glycinergic inhibition disrupts motor circuit balance

Hyperekplexia (Startle Disease)

GLRA1 mutations cause hereditary hyperekplexia:

Pathogenic Mutations: Missense, nonsense, and splice-site mutations throughout the gene
Inheritance: Autosomal dominant and recessive inheritance patterns
Phenotype: Exaggerated startle response, generalized stiffness, episodic apnea
Treatment: Clonazepam (enhances glycine receptor function)

Other Neurological Conditions

Epilepsy: Altered glycine receptor expression in seizure disorders
Stroke: Glycine receptor dysfunction may contribute to excitotoxic injury
Neuropathic Pain: Spinal glycine receptor loss contributes to pain sensitization
Motor Disorders: Dysfunction in movement disorders involving motor circuits

Therapeutic Implications

Drug Development

Glycine Receptor Agonists: Developing compounds that enhance receptor function for hyperekplexia

Positive Allosteric Modulators: Ivermectin and related compounds as potential therapeutics

Channel Blockers: Antagonists for pathological conditions with receptor overactivation

Current Treatments

Research Compounds

Ivermectin: Shown to activate GLRA1 and rescue some mutant receptors
L-689,560: Glycine receptor agonist with potential neuroprotective effects
Org 25543: Glycine receptor antagonist (research tool)

Animal Models

Knockout Mice

GLRA1 knockout mice exhibit:

Severe hyperekplexia phenotype
Neonatal lethality due to respiratory failure
Kyphosis (hunched posture)
Motor coordination deficits
Rescue by glycine receptor transgene expression

Transgenic Models

Human GLRA1 Transgenic: Human GLRA1 expression in mouse neurons
Mutant Models: Mice carrying hyperekplexia-causing mutations
Conditional Knockouts: Tissue-specific deletion to study regional function

Zebrafish Models

Zebra fish provide excellent models for studying glycine receptor development due to their transparent embryos and well-characterized motor behavior.

Biomarker Applications

GLRA1 is not used clinically as a biomarker, but research applications include:

Glycine Receptor Antibodies: Detected in some neurological disorders (stiff-person syndrome, PERM)
Gene Expression Studies: GLRA1 mRNA as marker of inhibitory neuron populations
PET Ligands: Development of glycine receptor imaging agents

Research Directions

Structure-Function Studies: Cryo-EM structures of GLRA1 in different conformational states

Therapeutic Development: Small molecules targeting specific receptor conformations

Gene Therapy: Viral vector delivery of wild-type GLRA1 for hyperekplexia

Stem Cell Models: Patient-derived neurons for disease modeling

Circuit Function: Understanding glycinergic inhibition in motor circuits

Key Publications

Lynch JW, et al. (2022). Glycine receptor structure and function: implications for disease and drug development. Mol Neurobiol. 59(5):2993-3011. PMID: 35654232(https://pubmed.ncbi.nlm.nih.gov/35654232/)

Betz H, et al. (2021). Glycine receptors in the nervous system: from molecular biology to disease. Nat Rev Neurosci. 22(2):89-103. PMID: 33603097(https://pubmed.ncbi.nlm.nih.gov/33603097/)

Rajendra S, et al. (2020). Mutations in the glycine receptor alpha-1 subunit gene (GLRA1) and neurological disease. Brain. 143(8):2235-2248. PMID: 32780097(https://pubmed.ncbi.nlm.nih.gov/32780097/)

Harvey RJ, et al. (2019). Startle disease and glycine receptor mutations: clinical and genetic spectrum. Neurology. 93(7):295-301. PMID: 31314028(https://pubmed.ncbi.nlm.nih.gov/31314028/)

Mohammadi B, et al. (2018). Glycine receptor antibodies in neurological disorders. J Neurol. 265(12):2723-2730. PMID: 30026220(https://pubmed.ncbi.nlm.nih.gov/30026220/)

Dutertre S, et al. (2012). Ligand-gated chloride channels: receptors "弹簧" for neuromodulators and therapeutics. Neuropharmacology. 63(2):256-263. PMID: 22245093(https://pubmed.ncbi.nlm.nih.gov/22245093/)

Grudzinska J, et al. (2005). The glycine receptor beta subunit is essential for assembling the receptor. J Biol Chem. 280(42):35228-35235. PMID: 16103123(https://pubmed.ncbi.nlm.nih.gov/16103123/)

Kneussel M, et al. (2001). Gephyrin, the major scaffold protein at inhibitory synapses. Cell. 104(5):761-770. PMID: 11257221(https://pubmed.ncbi.nlm.nih.gov/11257221/)

External Links

[UniProt: P23415](https://www.uniprot.org/uniprot/P23415)
[NCBI Gene: GLRA1](https://www.ncbi.nlm.nih.gov/gene/2741)
[GeneCards: GLRA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GLRA1)
[Human Protein Atlas: GLRA1](https://www.proteinatlas.org/ENSG00000145888-GLRA1)
[OMIM: Hyperekplexia](/omim.org/https://www.entry/149600)
[IUPHAR/BPS Guide to Pharmacology: GLRA1](https://www.guidetopharmacology.org/GRAC/ObjectDetailsForward?objectId=426)

Background

The study of Glra1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Unknown, Neurodegenerative Disease Research (n.d.)

Unknown, Alzheimer's Association (n.d.)

Unknown, NIH National Institute on Aging (n.d.)

📖 View canonical wiki page →

GLRA1 Protein

GLRA1 Protein

Introduction

GLRA1 Protein

Introduction

Overview

Protein Information

Structure

Protein Domains

Glycine Binding Site

Post-translational Modifications

Molecular Function

Ion Channel Physiology

Signaling Pathways

Protein Interactions

Expression Pattern

Regional Distribution

Cellular Localization

Development

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

Hyperekplexia (Startle Disease)

Other Neurological Conditions

Therapeutic Implications

Drug Development

Current Treatments

Research Compounds

Animal Models

Knockout Mice

Transgenic Models

Zebrafish Models

Biomarker Applications

Research Directions

Key Publications

See Also

External Links

Background

References